Differences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinoma

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Räsänen, Kati ^a   Virtanen, Ismo ^b   Salmenperä, Pertteli ^a   Grenman, Reidar ^c   Vaheri, Antti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALVASCULIN; CYCLOOXYGENASE 2; KERATINOCYTE GROWTH FACTOR;

ARTICLE; CANCER CELL CULTURE; CANCER RECURRENCE; CARCINOGENESIS; CELL ACTIVATION; CELL HETEROGENEITY; CELL STRAIN; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUTH CARCINOMA; NEMOSIS; PROTEIN ANALYSIS; SPHEROID CELL; SQUAMOUS CELL CARCINOMA; UPREGULATION; ADULT; AGED; CYTOLOGY; FEMALE; GENE EXPRESSION PROFILING; INFLAMMATION; MALE; METABOLISM; MOUTH TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; TUMOR CELL LINE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; MALE; MOUTH NEOPLASMS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN;

EID: 70149087315     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006879     Document Type: Article

References (46)

1. Orimo A, Weinberg RA (2006) Stromal fibroblasts in cancer: A novel tumor promoting cell type. Cell Cycle 5: 1597-1601.
2. Tsellou E, Kiaris H (2008) Fibroblast independency in tumors: Implications in cancer therapy. Future Oncol 4: 427-432.
3. Augsten M, Hagglof C, Olsson E, Stolz C, Tsagozis P, et al. (2009) CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proc Natl Acad Sci U S A 106: 3414-3419.
4. De Wever O, Demetter P, Mareel M, Bracke M (2008) Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 123: 2229-2238.
5. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
6. Hinz B (2007) Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 127: 526-537.
7. Sherbet GV (2009) Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett 280: 15-30.
8. Kelly T (2005) Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): Cell-surface proteases that activate cell signaling and are potential targets for cancer therapy. Drug Resist Updat 8: 51-58.
9. Schor SL, Schor AM (1987) Clonal heterogeneity in fibroblast phenotype: Implications for the control of epithelial-mesenchymal interactions. Bioessays 7: 200-204.
10. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, et al. (2002) Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 99: 12877-12882.
11. Sugimoto H, Mundel TM, Kieran MW, Kalluri R (2006) Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 5: 1640-1646.
12. Micke P, Ostman A (2005) Exploring the tumour environment: Cancer-associated fibroblasts as targets in cancer therapy. Expert Opin Ther Targets 9: 1217-1233.
13. Vaheri A, Enzerink A, Rasanen K, Salmenpera P (2009) Nemosis, a novel way of fibroblast activation, in inflammation and cancer. Exp Cell Res 315: 1633-1638.
14. Bizik J, Kankuri E, Ristimaki A, Taieb A, Vapaatalo H, et al. (2004) Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression. Cell Death Differ 11: 183-195.
15. Kankuri E, Cholujova D, Comajova M, Vaheri A, Bizik J (2005) Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res 65: 9914-9922.
16. Salmenpera P, Kankuri E, Bizik J, Siren V, Virtanen I, et al. (2008) Formation and activation of fibroblast spheroids depend on fibronectin-integrin interaction. Exp Cell Res 314: 3444-3452.
17. Räsänen K, Salmenperä P, Baumann M, Virtanen I, Vaheri A (2008) Nemosis of fibroblasts is inhibited by benign HaCaT keratinocytes but promoted by malignant HaCaT cells. Mol Oncol 2: 340-348.
18. Enzerink A, Salmenperä P, Kankuri E, Vaheri A (2009) Clustering of fibroblasts induces proinflammatory chemokine secretion promoting leukocyte migration. Mol Immunol 46: 1787-1795.
19. Siren V, Salmenpera P, Kankuri E, Bizik J, Sorsa T, et al. (2006) Cell-cell contact activation of fibroblasts increases the expression of matrix metalloproteinases. Ann Med 38: 212-220.
20. Kramer RH, Shen X, Zhou H (2005) Tumor cell invasion and survival in head and neck cancer. Cancer Metastasis Rev 24: 35-45.
21. Hassan NM, Tada M, Hamada J, Kashiwazaki H, Kameyama T, et al. (2008) Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer. Cancer Lett 270: 108-119.
22. Sheikh Ali MA, Gunduz M, Nagatsuka H, Gunduz E, Cengiz B, et al. (2008) Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma. Cancer Sci 99: 1589-1594.
23. Gold KA, Lee HY, Kim ES (2009) Targeted therapies in squamous cell carcinoma of the head and neck. Cancer 115: 922-935.
24. Hamakawa H, Nakashiro K, Sumida T, Shintani S, Myers JN, et al. (2008) Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer. Head Neck 30: 800-809.
25. Honkanen J, Rantanen V, Kulmala J, Grenman R, Klemi P, et al. (1998) Radiosensitivity of dermal and tumor fibroblasts derived from the same patient. J Cancer Res Clin Oncol 124: 415-420.
26. Haikonen J, Rantanen V, Pekkola K, Kulmala J, Grenman R (2003) Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual? Int J Cancer 103: 784-788.
27. Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, et al. (2008) No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 40: 650-655.
28. Ohtani N, Mann DJ, Hara E (2009) Cellular senescence: Its role in tumor suppression and aging. Cancer Sci 100: 792-797.
29. Sund M, Kalluri R (2009) Tumor stroma derived biomarkers in cancer. Cancer Metastasis Rev 28: 177-183.
30. Shannon DB, McKeown ST, Lundy FT, Irwin CR (2006) Phenotypic differences between oral and skin fibroblasts in wound contraction and growth factor expression. Wound Repair Regen 14: 172-178.
31. Kellermann MG, Sobral LM, da Silva SD, Zecchin KG, Graner E, et al. (2008) Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: Induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol 44: 509-517.
32. Shaoul R, Eliahu L, Sher I, Hamlet Y, Miselevich I, et al. (2006) Elevated expression of FGF7 protein is common in human gastric diseases. Biochem Biophys Res Commun 350: 825-833.
33. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, et al. (2009) The role of vascular endothelial growth factor in wound healing. J Surg Res 153: 347-358.
34. Jin C, Wang F, Wu X, Yu C, Luo Y, et al. (2004) Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors. Cancer Res 64: 4555-4562.
35. Daly AJ, McIlreavey L, Irwin CR (2008) Regulation of HGF and SDF-1 expression by oral fibroblasts-implications for invasion of oral cancer. Oral Oncol 44: 646-651.
36. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, et al. (1998) Tumor induction of VEGF promoter activity in stromal cells. Cell 94: 715-725.
37. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, et al. (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011.
38. Barclay WW, Woodruff RD, Hall MC, Cramer SD (2005) A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology 146: 13-18.
39. Ao M, Franco OE, Park D, Raman D, Williams K, et al. (2007) Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res 67: 4244-4253.
40. San Francisco IF, DeWolf WC, Peehl DM, Olumi AF (2004) Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts. Int J Cancer 112: 213-218.
41. Ruutu M, Johansson B, Grenman R, Syrjanen S (2005) Two different global gene expression profiles in cancer cell lines established from etiologically different oral carcinomas. Oncol Rep 14: 1511-1517.
42. Virtanen I, Miettinen M, Lehto VP, Kariniemi AL, Paasivuo R (1985) Diagnostic application of monoclonal antibodies to intermediate filaments. Ann N Y Acad Sci 455: 635-648.
43. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
44. Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
45. Zheng J, Vaheri A (1995) Human skin fibroblasts induce anchorage-independent growth of HPV-16-DNA-immortalized cervical epithelial cells. Int J Cancer 61: 658-665.
46. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92: 9363-9367.